ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Historical Holders from Q4 2017 to Q3 2025

Symbol: KIDS on Nasdaq
Type / Class: Equity / Class A common stock, $0.00025 par value
Shares outstanding: 25,086,311
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 16,501,828
Holdings value: $305,775,919
% of all portfolios: 0.001%
Number of holders: 110
Number of buys: 51
Number of sells: -59
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
INTEGRATED CORE STRATEGIES (US) LLC	5.5%		$25,768,856		1,390,656		Millennium Management LLC	29 Oct 2025
BlackRock, Inc.	4.96%		$26,436,748		1,230,784		BlackRock, Inc.	30 Jun 2025
BROWN CAPITAL MANAGEMENT LLC	4.31%	-34.7%	$20,035,007	-$10,919,822	1,081,220	-35.3%	Brown Capital Management, LLC	30 Sep 2025

Institutional Holders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	16,501,828	$305,775,919	-$6,454,981	$211,242	$270,538	$18.53	110
2025 Q2	16,817,981	$361,248,552	+$2,212,295	$244,872	$0	$21.48	116
2025 Q1	16,691,588	$411,125,012	+$5,143,009	$2,463	$12,315	$24.63	114
2024 Q4	16,501,406	$382,504,159	+$773,471	$6,954	$53,314	$23.18	107
2024 Q3	16,333,743	$442,837,473	+$1,584,968	$8,133	$436,471	$27.11	121
2024 Q2	16,242,247	$467,138,707	+$10,095,978	$2,876	$460,160	$28.76	120
2024 Q1	15,892,946	$463,440,165	-$12,906,846	$1,046,844	$277,020	$29.16	117
2023 Q4	16,261,994	$528,667,001	-$251,450	$68,271	$269,833	$32.51	126
2023 Q3	16,271,554	$521,018,497	+$6,205,213	$99,200	$147,200	$32	115
2023 Q2	15,984,589	$701,031,443	-$10,062,157	$57,005	$39,465	$43.85	120
2023 Q1	16,213,938	$717,721,563	+$13,280,226	$101,867	$341,033	$44.29	120
2022 Q4	15,969,552	$634,638,489	-$20,370,351	$123,163	$361,543	$39.73	117
2022 Q3	15,319,596	$706,913,920	+$7,022,250	$752,000	$0	$46.14	120
2022 Q2	15,147,316	$653,533,661	+$9,822,525	$1,774,000	$4,695,155	$43.15	112
2022 Q1	14,882,764	$803,548,443	+$23,227,965	$416,000		$53.99	121
2021 Q4	14,446,519	$864,710,320	-$43,598,809		$0	$59.86	123
2021 Q3	14,787,776	$968,927,802	-$16,120,535	$0	$236,000	$65.51	140
2021 Q2	15,040,814	$950,122,354	+$34,742,154	$227,000		$63.18	136
2021 Q1	14,650,983	$714,225,765	-$10,678,703	$717,000	$0	$48.75	122
2020 Q4	15,132,644	$624,376,779	+$44,734,958	$2,096,000	$487,000	$41.25	130
2020 Q3	13,957,347	$640,952,762	+$41,183,608	$656,000	$941,000	$45.92	122
2020 Q2	13,071,781	$571,934,696	+$88,263,492	$967,000	$0	$43.76	127
2020 Q1	11,071,736	$438,826,875	+$57,686,504		$226,000	$39.64	104
2019 Q4	9,512,953	$446,965,037	+$84,907,154		$244,000	$46.99	104
2019 Q3	7,509,308	$264,801,326	+$8,203,360		$212,000	$35.26	88
2019 Q2	7,203,561	$280,872,895	+$1,251,778			$39	98
2019 Q1	7,148,503	$316,165,724	+$23,434,585			$44.23	93
2018 Q4	6,630,503	$231,241,733	+$50,275,283			$34.88	75
2018 Q3	5,186,095	$189,981,535	+$5,589,115			$36.64	63
2018 Q2	5,138,887	$136,915,101	+$18,977,050			$26.64	55
2018 Q1	4,514,822	$67,993,229	+$3,724,248			$15.06	46
2017 Q4	4,158,182	$79,791,894	+$79,791,894			$19.19	49